The aim of this study was to determine the concentrations of irisin, chemerin, lipocalin-2 and omentin-1 in the serum and peritoneal fluid of patients with ovarian cancer, as well as in the serum of patients with benign ovarian lesions. This evidence concerns the gene FNDC5 and ovarian carcinoma.